Cell Press agreement enables open access publishing


FinELib and Elsevier have signed a Read and Publish agreement for Cell Press journals for the term 2022–2024.

With the new agreement, researchers affiliated with the participating organisations can publish their articles open access without extra costs in about 40 Cell Press hybrid journals in the field of medical and natural sciences.

The agreement covers 10 FinELib member organisations, who yearly have published about 30 articles in total in Cell Press hybrid journals.

In addition, the agreement allows researchers and students to access Cell Press journals subscribed by the organisations.

More information on how to publish open access in Cell Press journals

The license agreement 2022-2024